How Solvay’s Latest Earnings Set the Stage for Investors
Solvay (ENXTBR:SOLB) reported its second quarter and first half 2026 results on 29 July, showing lower sales and net income compared with the same periods a year earlier.
For the quarter, sales were €1,031 million versus €1,102 million a year ago, with net income at €63 million compared with €97 million. Basic earnings per share from continuing operations came in at €0.60, down from €0.92.
Over the first six months of 2026, Solvay reported sales of €2,028 million against €2,223 million a year before. Net income was €139 million, compared with €196 million, with basic earnings per share from continuing operations at €1.33 versus €1.88.
See our latest analysis for Solvay.
Following the earnings announcement on 29 July, Solvay’s share price has held around €26.72, with a 30 day share price return of 1.91% and a year to date share price return that is down 2.27%. The 3 year total shareholder return of 50.87% points to stronger longer term compounding despite more muted recent momentum.
If you are weighing Solvay’s recent moves and want to widen your watchlist in the materials and energy infrastructure space, this could be a helpful moment to review 36 power grid technology and infrastructure stocks.
Given Solvay’s softer earnings and mostly flat recent share move, it is fair to ask whether the price now reflects the underlying chemicals business or simply cooler sentiment after a strong three year run. How does the current valuation stack up?
Most Popular Narrative: 6.5% Overvalued
Solvay’s most followed narrative points to a fair value of €25.10 compared with the latest close at €26.72, which frames the stock as slightly ahead of that central estimate while still anchored to detailed earnings and margin assumptions.
Ramp-up of new, highly competitive soda ash and rare earth capacities offers scope for improved profitability and share gains once market demand normalizes or supply rationalization (e.g., Chinese plant closures) occurs; this operational leverage may be underappreciated in the current valuation.
Analysts are baking in falling revenue, rising profit margins and a higher future P/E all at once. It is worth examining which mix of earnings recovery, capital discipline and rare earth contribution underpins that fair value story.
Result: Fair Value of €25.10 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the Solvay narrative can shift quickly if pricing pressure in soda ash persists or if environmental cash outflows reduce available funds for rare earth expansion.
Find out about the key risks to this Solvay narrative.
Another View: Solvay Through a Multiples Lens
While the narrative fair value for Solvay points to only modest downside from the current share price, the picture shifts when looking at simple sales based pricing. The stock trades on a P/S of 0.6x, compared with 1.1x for the wider European Chemicals industry and 0.7x for close peers, yet the fair ratio is 0.5x. That gap suggests investors need to weigh whether the discount to the sector or the premium to the fair ratio matters more for their own risk tolerance.
For a closer look at how the market pricing compares with this fair ratio view, and how the numbers stack up in detail, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With the picture for Solvay looking mixed, it makes sense to move quickly and test the numbers yourself against both the concerns and the potential upside. To see both sides in one place, review the 2 key rewards and 2 important warning signs
Looking For More Investment Ideas Beyond Solvay?
If Solvay has sharpened your focus on quality, do not stop here. Broader ideas can help you stress test your thinking and spot opportunities early.
- Zero in on companies with strong balance sheets and resilient fundamentals by checking the solid balance sheet and fundamentals stocks screener (422 results).
- Hunt for potential mispriced opportunities that combine quality with attractive pricing through the 252 high quality undervalued stocks.
- Round out your watchlist with companies that may be flying under the radar by using the screener containing 550 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com